Mindfulness Meditation for Sleep Disorders
(REST Trial)
Trial Summary
What is the purpose of this trial?
Sleep disturbance has a range of negative effects on psychosocial and biological processes important for academic and social success as well as mental and physical health among adolescents and young adults. Limited, inconsistent, and poor quality sleep lead to anxiety, depressive feelings, loneliness, and fatigue over time. These symptoms, in turn, interfere with the ability to get a good night's rest. Sleep disruption can also upregulate inflammatory processes during the years of adolescence and young adulthood in ways that can create risk for the development of chronic health conditions (e.g., diabetes, depression, cardiovascular disease) in later adulthood. Sleep, however, is also a modifiable health behavior, leading many institutions to embark upon efforts to improve the sleep of their students. The challenge is to identify programs and interventions that can simultaneously improve sleep, be delivered at scale, and be easily completed by students. UCLA has developed and validated a group-based mindfulness intervention, Mindful Awareness Practices (MAPs), that has demonstrated beneficial effects on sleep in adults and may offer a promising, scalable approach for reducing sleep disturbance and improving associated psychological and biological outcomes in college students. However, this approach requires validation in this population relative to sleep education programs, which increasingly dominate the college landscape. To address this important public health problem, the investigators propose to conduct a single site, two-arm, parallel group randomized controlled trial to test the efficacy of the validated, group-based, six-week MAPs intervention vs. sleep education, an active time and attention matched control condition, for first year undergraduate students who report poor sleep at this critical transition year. The investigators are aiming to enroll approximately 240 participants. Participants will complete questionnaires, provide blood samples for immune analysis and will be provided with wrist actigraphs to wear for 7 days, in order to collect objective measurements of sleep at pre- and post-intervention visits, and at a 3-month follow-up visit. Additional follow-up assessments will take place at 6-month, and 12-month post-intervention to evaluate persistence of effects.
Will I have to stop taking my current medications?
The trial excludes participants who use medications that may influence sleep or inflammation, so you may need to stop taking such medications to participate.
What data supports the effectiveness of the treatment Mindfulness Meditation for Sleep Disorders?
Research shows that mindfulness meditation can help improve sleep quality and reduce sleep disturbances, particularly in people with insomnia and cancer patients. It combines meditation with behavioral strategies to manage sleep issues and has been shown to reduce stress and improve emotional regulation, which can contribute to better sleep.12345
Is mindfulness meditation safe for treating sleep disorders?
Mindfulness meditation is generally considered safe, but some people may experience side effects like anxiety or discomfort. Severe reactions, such as psychosis, are rare and often linked to other factors like the intensity of practice or personal mental health history. Mindfulness programs are usually designed to be adaptable to avoid causing harm.678910
How is mindfulness meditation different from other treatments for sleep disorders?
Mindfulness meditation is unique because it combines meditation practices with behavioral strategies to help manage stress and emotions, which can improve sleep quality. Unlike medications or other therapies, it focuses on developing awareness and acceptance of thoughts and feelings, which can help individuals adapt to sleep disturbances.211121314
Research Team
Julienne E Bower, Ph.D.
Principal Investigator
University of California, Los Angeles
Andrew Fuligni, Ph.D.
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
The UCLA REST Study is for first-year undergraduate students at UCLA, aged 18-20, living in campus dorms and experiencing sleep issues as indicated by a score of 8+ on the Insomnia Severity Index. Students with mood or anxiety disorders, certain medical conditions, or prior mindfulness meditation instruction are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Eligible participants complete baseline assessments including questionnaires, blood samples, and actigraphy setup
Treatment
Participants attend weekly group sessions for Mindful Awareness Practices or Sleep Education over six weeks
Immediate Post-Intervention Assessment
Participants complete post-intervention assessments including questionnaires, blood samples, and actigraphy
Follow-up
Participants are monitored for long-term effects with assessments at 3, 6, and 12 months post-intervention
Treatment Details
Interventions
- Mindfulness Meditation
- Sleep Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor